Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Enterprise Value: 2020-2025

Historic Enterprise Value for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $3.3 billion.

  • Mirum Pharmaceuticals' Enterprise Value rose 109.84% to $3.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 245.02%. This contributed to the annual value of $1.7 billion for FY2024, which is 56.43% up from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Enterprise Value of $3.3 billion as of Q3 2025, which was up 49.23% from $2.2 billion recorded in Q2 2025.
  • Over the past 5 years, Mirum Pharmaceuticals' Enterprise Value peaked at $3.3 billion during Q3 2025, and registered a low of $155.8 million during Q2 2021.
  • Over the past 3 years, Mirum Pharmaceuticals' median Enterprise Value value was $1.3 billion (recorded in 2024), while the average stood at $1.5 billion.
  • Examining YoY changes over the last 5 years, Mirum Pharmaceuticals' Enterprise Value showed a top increase of 282.67% in 2021 and a maximum decrease of 44.05% in 2021.
  • Over the past 5 years, Mirum Pharmaceuticals' Enterprise Value (Quarterly) stood at $232.1 million in 2021, then skyrocketed by 101.28% to $467.3 million in 2022, then soared by 133.22% to $1.1 billion in 2023, then skyrocketed by 56.43% to $1.7 billion in 2024, then soared by 109.84% to $3.3 billion in 2025.
  • Its last three reported values are $3.3 billion in Q3 2025, $2.2 billion for Q2 2025, and $1.9 billion during Q1 2025.